Following instruction of O.G. Golodets, Deputy Chairman of the Government of the Russian Federation, of 03.06.2016 No ОГ-П12-3286 the Ministry of Healthcare of the Russian Federation has started development of a draft of law to tighten control over the quality of drugs in public circulation.
The aim of the draft of law is to enhance the federal public surveillance in the field of drug circulation.
The new document will be particularly focused on control of release into public circulation of medicinal drugs. It concerns tests in independent laboratories for drug quality control and analysis of information, provided by manufacturers, and institutions responsible for import of drugs into the Russian Federation, into the Federal executive authority for surveillance in the field of healthcare. Besides the draft of law will establish the principles of control of release of immunobiological drugs into civil circulation, performed by authorized federal executive authorities according to legislation of the Russian Federation on drug circulation.
Public discussion of the draft of law will continue to July 21, 2016.